Literature DB >> 9496351

Insulin and insulin-like growth factor I stimulate the proliferation of human ovarian theca-interstitial cells.

A J Duleba1, R Z Spaczynski, D L Olive.   

Abstract

OBJECTIVE: To determine whether insulin and insulin-like growth factor I (IGF-I) affect the proliferation of human theca-interstitial cells.
DESIGN: In vitro assays.
SETTING: University laboratory. PATIENT(S): Premenopausal women undergoing oophorectomy for benign conditions. INTERVENTION(S): Purified theca-interstitial cells were cultured in chemically defined media with or without insulin and IGF-I. MAIN OUTCOME MEASURE(S): The proliferation of cells was evaluated by determination of [3H] thymidine incorporation and cell counting. RESULT(S): Insulin and IGF-I stimulated DNA synthesis by theca-interstitial cells in a dose-dependent fashion. Insulin-like growth factor I had a greater potency than did insulin. The effects of both approached, but did not reach, the level of DNA synthesis observed in cultures exposed to 10% fetal bovine serum. Direct counting of theca-interstitial cells revealed that IGF-I significantly increased the total number of cells (36% above control), whereas insulin induced a modest and statistically nonsignificant increase in the cell number (14% above control). CONCLUSION(S): The present results support the hypothesis that insulin and IGF-I promote the mitotic activity of theca-interstitial cells. These effects may represent mechanisms that lead to hyperplasia of the thecal/stromal compartment in polycystic ovary syndrome.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9496351     DOI: 10.1016/s0015-0282(97)00473-1

Source DB:  PubMed          Journal:  Fertil Steril        ISSN: 0015-0282            Impact factor:   7.329


  16 in total

Review 1.  Polycystic ovary syndrome: What is it? Pathogenetic enigma and therapeutic dilemma.

Authors:  V Toscano
Journal:  J Endocrinol Invest       Date:  1998-10       Impact factor: 4.256

2.  Metformin: direct inhibition of rat ovarian theca-interstitial cell proliferation.

Authors:  Matthew A Will; Murugesan Palaniappan; Helle Peegel; Pradeep Kayampilly; K M J Menon
Journal:  Fertil Steril       Date:  2012-05-17       Impact factor: 7.329

3.  Evidence for statin therapy in polycystic ovary syndrome.

Authors:  Thozhukat Sathyapalan; Stephen L Atkin
Journal:  Ther Adv Endocrinol Metab       Date:  2010-02       Impact factor: 3.565

4.  Approach to the girl with early onset of pubic hair.

Authors:  Sharon E Oberfield; Aviva B Sopher; Adrienne T Gerken
Journal:  J Clin Endocrinol Metab       Date:  2011-06       Impact factor: 5.958

Review 5.  Scientific Statement on the Diagnostic Criteria, Epidemiology, Pathophysiology, and Molecular Genetics of Polycystic Ovary Syndrome.

Authors:  Daniel A Dumesic; Sharon E Oberfield; Elisabet Stener-Victorin; John C Marshall; Joop S Laven; Richard S Legro
Journal:  Endocr Rev       Date:  2015-10       Impact factor: 19.871

6.  Role of isoprenylation in simvastatin-induced inhibition of ovarian theca-interstitial growth in the rat.

Authors:  Izabela J Rzepczynska; Piotr C Piotrowski; Donna H Wong; Amanda B Cress; Jesus Villanueva; Antoni J Duleba
Journal:  Biol Reprod       Date:  2009-07-01       Impact factor: 4.285

Review 7.  Premature pubarche, ovarian hyperandrogenism, hyperinsulinism and the polycystic ovary syndrome: from a complex constellation to a simple sequence of prenatal onset.

Authors:  L Ibáñez; F de Zegher; N Potau
Journal:  J Endocrinol Invest       Date:  1998-10       Impact factor: 4.256

8.  Protein intake and ovulatory infertility.

Authors:  Jorge E Chavarro; Janet W Rich-Edwards; Bernard A Rosner; Walter C Willett
Journal:  Am J Obstet Gynecol       Date:  2008-02       Impact factor: 8.661

Review 9.  Clinical spectrum of premature pubarche: links to metabolic syndrome and ovarian hyperandrogenism.

Authors:  Lourdes Ibáñez; Rubén Díaz; Abel López-Bermejo; Maria Victoria Marcos
Journal:  Rev Endocr Metab Disord       Date:  2009-03       Impact factor: 6.514

Review 10.  HMG-CoA reductase inhibitors: do they have potential in the treatment of polycystic ovary syndrome?

Authors:  Pinar H Kodaman; Antoni J Duleba
Journal:  Drugs       Date:  2008       Impact factor: 9.546

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.